CardioMEMS

Abbott's implantable cardiac monitor CardioMEMS lands expanded FDA designation
By Laura Lovett | 01:19 pm | February 21, 2022
The system first landed clearance in 2014 for Class III heart failure patients. 
St. Jude receives FDA 510(k) clearance for mobile-enabled spinal cord stimulation trial system
By Aditi Pai | 10:06 am | July 16, 2015
St.
CardioMEMS gets FDA clearance for implanted artery pressure sensor, St. Jude to acquire it
By Aditi Pai | 09:59 am | May 29, 2014
Atlanta, Georgia-based health device maker CardioMEMS received FDA clearance for its CardioMEMS HF System, which monitors pulmonary artery pressure, but for patients who have experienced New York Heart Association (NYHA) Class III heart failure and have been hospitalized for heart failure in the previous year.
The 15 wireless health VC deals of 2009
By Brian Dolan | 05:52 am | December 29, 2009
Uptick in investments in medtech start-ups
By Brian Dolan | 08:51 am | September 04, 2009
Wireless sensor company CardioMEMS gets $22.1M in VC
By Brian Dolan | 08:46 am | August 26, 2009
Qualcomm: mHealth collapses time and space
By Brian Dolan | 07:38 am | February 18, 2009